What’s good for the heart may not be so healthy for other organs, says the latest study that links omega-3 fatty acids to an elevated risk of prostate cancer.
There’s a revolution occurring in cancer treatment, and it could mean the end of chemotherapy.
Researchers at Stanford University say infertility may put some men at higher risk of developing brain, prostate and testicular tumors as well as melanoma and lymphoma.
It’s called ibrutinib, and it’s a potential breakthrough in treating chronic lymphocytic leukemia (CLL) that could leave patients with fewer side effects than chemotherapy.
Another study is adding to the growing body of evidence that CT scans in childhood can be linked to cancer later on.
The advice to detect and treat cancers at the first opportunity may not apply to older men with prostate tumors, according to the latest study.
CT scans can reveal a remarkable amount of useful medical information, but more studies underscore the need to balance the benefits of that knowledge with the risks of being exposed to the scans’ small amounts of radiation.
There’s no positive side to developing skin cancer, but the latest research ties certain forms of the disease to a reduced risk of dementia.
It’s been 17 years since Dolly the sheep was cloned from a mammary cell. And now scientists applied the same technique to make the first embryonic-stem-cell lines from human skin cells.
Researchers announced the promising results of a new genetic test that can predict the most aggressive prostate cancers; New Jersey governor Chris Christie has gastric lap-band surgery, and moms who lick their babies’ pacifiers clean may be doing their kids’ immune systems a favor. These are some of the major stories making health news this week.
At her Seattle high school, Shannon Keating wears a hat to camouflage a head made bare by chemotherapy. In the hospital, surrounded by other teens her age, she’s more comfortable going bald. “I feel fine not wearing a hat …